Applied The Platelet Rich Fibrin in Chronic Periodontitis
Launched by ATATURK UNIVERSITY · Nov 2, 2015
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
PRF was developed in 2001 by Choukroun in France, it was the second generation fibrin adhesive, and was used to accelerate the soft and hard tissue healing. Many studies have shown beneficial effects of PRF on osteoconductive filler material in sinus lift operations, treatment of periodontal sulcus defect and treatment of furcation defects. Also PRF contains many growth factors. PRF accelerates periodontal regeneration through the gradually excreted growth factors and contributes to the bone regeneration. In this study, the investigators evaluated the effect of PRF on growth factors and its...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with CP who had pocket depth ≤ 5 mm and at least two area (grouped as Control and PRF) with horizontal bone loss after Phase I therapy
- Exclusion Criteria:
- • The subjects excluded in the study had history of systemic disease, were smokers, had allergy to any drug, had need for prophylaxis of antibiotic and had taken antibiotics at least 6 months
About Ataturk University
Atatürk University, located in Erzurum, Turkey, is a prominent academic institution dedicated to advancing research and education across various disciplines. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative medical research aimed at improving patient outcomes and contributing to the global body of health knowledge. Committed to ethical standards and rigorous scientific methodologies, Atatürk University collaborates with healthcare professionals, researchers, and regulatory bodies to ensure the integrity and efficacy of its clinical trials, ultimately enhancing the quality of care and driving advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Denizli, , Turkey
Patients applied
Trial Officials
Yasin ÇiÇEK
Study Chair
Adiyaman University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials